Logo image of GYL.OL

GYLDENDAL ASA (GYL.OL) Stock Analyst Earnings Estimates

OSL:GYL - Euronext Oslo - NO0004288200 - Common Stock - Currency: NOK

454  +54 (+13.5%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
GYL.OL revenue by date.GYL.OL revenue by date.
2.678B
6.22%
2.686B
0.31%
2.731B
1.67%
EBITDA
YoY % growth
GYL.OL ebitda by date.GYL.OL ebitda by date.
367.302M
9.33%
331.688M
-9.70%
383.764M
15.70%
EBIT
YoY % growth
GYL.OL ebit by date.GYL.OL ebit by date.
93.593M
13.68%
51.4M
-45.08%
107.517M
109.18%
Operating Margin
GYL.OL operating margin by date.GYL.OL operating margin by date.
3.50%1.91%3.94%
EPS
YoY % growth
GYL.OL eps by date.GYL.OL eps by date.
N/AN/AN/A

All data in NOK

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in NOK

Recent Earnings VS Estimates Surprises (NOK)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (NOK)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
1.659B
2.69%
%
Q2 2024
Q2Q % growth
1.072B
0.14%
%
Q4 2023
Q2Q % growth
1.616B
-1.32%
%
Q2 2023
Q2Q % growth
1.071B
2.89%
%
Q4 2022
Q2Q % growth
1.637B
1.20%
%
Q2 2022
Q2Q % growth
1.04B
15.23%
%
Q4 2021
Q2Q % growth
1.618B
5.98%
%
Q2 2021
Q2Q % growth
902.947M
10.52%
%
Q4 2020
Q2Q % growth
1.527B
18.75%
%
Q2 2020
Q2Q % growth
816.966M
9.53%
%
GYL.OL Yearly Revenue VS EstimatesGYL.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A